Vaxcyte, Inc.·4

Mar 14, 5:03 PM ET

Sauer Paul 4

4 · Vaxcyte, Inc. · Filed Mar 14, 2022

Insider Transaction Report

Form 4
Period: 2022-03-10
Sauer Paul
SVP Process Dev, Manufacturing
Transactions
  • Sale

    Common Stock

    2022-03-10$25.00/sh6,000$150,00031,125 total
Footnotes (1)
  • [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION